TY - JOUR AU - Hou, Helei AU - Jia, Dongmei AU - Yan, Weihua AU - Zhang, Xiaoping AU - Wang, Chunbao AU - Li, Yujun AU - Chen, Hua AU - Huang, Weiqing AU - Li, Zhuokun AU - Zhang, Xiaochun PY - 2020 TI - KIT/PDGFRA/KDR amplification defines a novel molecular subtype of adenoid cystic carcinoma patients who may benefit from treatment with tyrosine kinase inhibitors JF - Translational Cancer Research; Vol 9, No 8 (August 23, 2020): Translational Cancer Research Y2 - 2020 KW - N2 - UR - https://tcr.amegroups.org/article/view/42077